|
Name: CUMYL-PEGACLONE (5-pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one)
Type: Synthetic cannabinoid
AKA: CUMYL-PEGACLONE; SGT-151
![CUMYL-PEGACLONE (5-pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one) image](https://grammasearch.com/dev/v2/aiimages/cumyl-pegaclone_%285-pentyl-2-%282-phenylpropan-2-yl%29pyrido%5B4%2C3-b%5Dindol-1-one%29.png)
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
![CUMYL-PEGACLONE (5-pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one) image](/dev/v2/pages/pubchem_images/126315726.png)
|
|
IV. History
Cumyl-Pegaclone, a synthetic cannabinoid, emerged in the 2010s. It is part of a class of compounds developed for their psychoactive effects. Its use in synthetic cannabis products highlights ongoing issues with synthetic cannabinoids, including health risks and regulatory responses.
|
|
V. Legal Information
Cumyl-PEGACLONE, a synthetic cannabinoid, is often regulated under analog laws due to its psychoactive effects. Its legal status varies by jurisdiction.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Cumyl-PEGACLONE is a synthetic cannabinoid with potent psychoactive effects. As an upper, it induces euphoria and altered perception. Short-term effects include increased heart rate and potential anxiety, while long-term use may lead to psychological issues. Overdose risks involve severe agitation and cardiovascular problems. Safe use involves cautious dosing, and recent research highlights its potency and risks.  |
|
VII. Psychological Effects
Cumyl-pegaclone, a synthetic cannabinoid, affects cannabinoid receptors, leading to altered mood and perception. Immediate effects include euphoria and relaxation, while long-term use may cause cognitive impairments and psychological issues. Research highlights potential for severe mental health disturbances with chronic use.
 |
|
VIII. Culture
Cumyl-PEGACLONE is a synthetic cannabinoid, classifying it as a downer. Short-term use induces relaxation and altered perceptions, while long-term use can lead to dependence and cognitive impairment. Overdose risks include severe sedation, cognitive impairment, and potential psychosis. Safe dosages are not well-established, with minimal use recommended. Recent research highlights its potency and associated risks of cognitive effects. Physical effects include drowsiness, altered perceptions, and potential for impaired motor skills.
 |